Preparations and laboratory control of an oral anti-coli vaccine
Triau, R.; Ayme, G.; Donikian, R.; Mynard, M.C.; Valette, L.
Progress in Immunobiological Standardization 4: 380-385
1970
ISSN/ISBN: 0079-6344 PMID: 4991589 Document Number: 27787
Document emailed within 1 workday
Related Documents
Wennerås, C.; Czerkinsky, C.; Svennerholm, A.M. 1995: Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine Advances in Experimental Medicine and Biology 371b: 1641-1644Mukhopadhyay, A.; Bhatia, P.K.; Majumdar, S.S. 1998: Preliminary studies with recombinant chorionic gonadotropin beta-subunit produced in Escherichia coli for use as an antigen in a birth control vaccine American Journal of Reproductive Immunology 39(3): 172-182
Gangarosa, E.J.; Galazka, A.M.; Wolfe, C.R.; Phillips, L.M.; Gangarosa, R.E.; Miller, E.; Chen, R.T. 1998: Impact of anti-vaccine movements on pertussis control: the untold story Lancet 351(9099): 356-361
Loginova, I.V.; Deriabin, P.G.; Tikhomirov, E.E.; Karpova, E.F. 2007: Tissue culture inactivated vaccine for the prevention of Japanese encephalitis: experimental and laboratory process and control layout Voprosy Virusologii 52(3): 26-29
Langer, B.; Muraco, B.; Manasterski, J.; Bechara, M.J.; Sitrângulo Júnior, C.; Puech-Leão, L.E. 1984: Laboratory control of the effect of anti-vitamins K on blood coagulation Revista do Hospital das Clinicas 39(1): 12-17
Hummel, L. 1988: Problems of the laboratory control of oral anticoagulant treatment Folia Haematologica 115(4): 529-531
Kopeć, M.; Lopaciuk, S. 1987: Problems of laboratory control of treatment with oral anticoagulants Polski Tygodnik Lekarski 42(30): 929-932
Dima, V.F.; Ionescu, M.D.; Palade, R.; Balotescu, C.; Becheanu, G.; Dima, S.V. 2001: Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine Roumanian Archives of Microbiology and Immunology 60(1): 27-54
Thomson, J.M.; Chart, I.S. 1970: The system for laboratory control of oral anticoagulant therapy using the British comparative thromboplastin Journal of Medical Laboratory Technology 27(2): 207-212
Unanov, S.S.; Bochkov, R.A.; Alekseeva, A.K.; Kaptosova, T.I.; Levchenko, E.N. 1977: Results of studying a live mumps vaccine from strain L-3 manufactured by the Moscow Research Institute of Viral Preparations. The epidemiological effectiveness of the vaccine Voprosy virusologii 1977(1): 59-61
Moon, H.W.; Rogers, D.G.; Rose, R. 1988: Effects of an orally administered live Escherichia coli pilus vaccine on duration of lacteal immunity to enterotoxigenic Escherichia coli in swine American Journal of Veterinary Research 49(12): 2068-2071
Barocci, S.; Fenoglio, D.; Leprini, A.; Nocera, A. 1990: Anti-HLA antibodies (Ab1) and anti-idiotypic antibodies (Ab2) directed against Anti-HLA Ab1 in various preparations of polyspecific immunoglobulins for intravenous use Bollettino della Societa Italiana di Biologia Sperimentale 66(12): 1193-1200
Ashley, K.C. 1986: The anti-bacterial activity of topical anti-infective eye preparations Medical Laboratory Sciences 43(2): 157-162
Más Lago, P.; Díaz, J.; Díaz Gonzalez, M.; Goyenechea Hernández, A.; Barrio Olivera, J.; Fonseca Quintana, M.; Morier Díaz, L.; Sarmiento Pérez, L.; Palomera Puente, R. 2005: Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine Revista Cubana de Medicina Tropical 57(2): 111-119
Townsend, J.S.; Steele, C.Brooke.; Hayes, N.; Bhatt, A.; Moore, A.R. 2017: Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program Journal of Women's Health 26(3): 200-206
Bousicaux, A. 1976: Standardization of the control technics of Clostridium perfringens vaccine. Use of a reference vaccine Developments in Biological Standardization 32: 45-61
Troy, S.B.; Musingwini, G.; Halpern, M.S.; Huang, C.; Stranix-Chibanda, L.; Kouiavskaia, D.; Shetty, A.K.; Chumakov, K.; Nathoo, K.; Maldonado, Y.A. 2013: Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants Journal of Infectious Diseases 208(4): 672-678
Deshmukh, U.S.; Talwar, G.P.; Gupta, S.K. 1994: IgG subclass distribution of anti-hCG and anti-diphtheria toxoid antibodies in women immunized with a beta-hCG based immunocontraceptive vaccine Journal of Reproductive Immunology 26(1): 65-72
Kihm, U. 1976: Comparison of a bivalent anti-foot-and-mouth disease vaccine with oil adjuvant to a vaccine with DEAE-dextran adjuvant in swine Developments in Biological Standardization 35: 149-153
Thilo, W.; Hempel, H.C.; Grimm, J.; Hayduk, J.; Starke, G. 1970: Inactivated oral Sh. sonnei vaccine. II. Formation and determination of humoral agglutinins following oral vaccination Das Deutsche Gesundheitswesen 25(6): 261-264